A Multi-Center, Open-Label, Phase II Study of Sequential, Single-Agent Obatoclax Mesylate (GX15-070MS) Followed by a Combination With Rituximab to Patients With Previously-Untreated Follicular Lymphoma (FL).
Phase of Trial: Phase II
Latest Information Update: 25 Jul 2016
At a glance
- Drugs Obatoclax (Primary) ; Rituximab
- Indications Follicular lymphoma
- Focus Therapeutic Use
- 14 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Sep 2010 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
- 01 Aug 2008 Status changed from recruiting to in progress, as reported by ClinicalTrials.gov.